8-K: Alzamend Neuro Changes Auditors, Appoints Haskell & White LLP

Sentiment:

8-K Filing


Alzamend Neuro, Inc. has dismissed Baker Tilly US, LLP and appointed Haskell & White LLP as its new independent registered public accounting firm, effective May 5, 2024.

Worse than expectedThe previous auditor's report included an explanatory paragraph about the company's ability to continue as a going concern, indicating financial instability.The company disclosed a material weakness in its internal controls over financial reporting for the fiscal years ended April 30, 2023 and 2022.

Summary

  • Alzamend Neuro, Inc. has changed its independent registered public accounting firm.
  • Baker Tilly US, LLP was dismissed on May 5, 2024, by the Audit Committee of the Board of Directors.
  • The dismissal was not due to any disagreements on accounting principles, financial statement disclosure, or auditing scope.
  • Baker Tilly's reports for fiscal years ended April 30, 2023 and 2022 did not contain adverse opinions or disclaimers, but the 2023 report included an explanatory paragraph about the company's ability to continue as a going concern.
  • The company had previously disclosed a material weakness in its internal controls over financial reporting for the fiscal years ended April 30, 2023 and 2022.
  • Haskell & White LLP was appointed as the new independent registered public accounting firm, effective May 5, 2024.
  • The company did not consult with Haskell & White LLP on any matters described in Items 304(a)(2)(i) and (ii) of Regulation S-K during the past two fiscal years and subsequent interim periods.

Sentiment

Score: 3

Explanation: The change in auditors itself is neutral, but the going concern note and material weakness in internal controls are significant negative indicators.

Positives

  • The change in auditors was not due to any disagreements on accounting or auditing matters, suggesting a smooth transition.
  • Baker Tilly agreed with the company's disclosures regarding the change in auditors.

Negatives

  • The company had a material weakness in its internal controls over financial reporting for the fiscal years ended April 30, 2023 and 2022.
  • Baker Tilly's 2023 report included an explanatory paragraph about the company's ability to continue as a going concern, indicating financial uncertainty.

Risks

  • The material weakness in internal controls over financial reporting could lead to future issues.
  • The going concern note in the previous auditor's report indicates potential financial instability.

Industry Context

Changes in auditors are not uncommon, but the reasons for the change and the previous auditor's going concern note are important factors to consider. The appointment of a new auditor is a standard process for companies.

Comparison to Industry Standards

  • The change of auditors is a common practice in the industry, but the circumstances surrounding the change, such as the going concern note and material weakness in internal controls, are not typical.
  • Companies like Cassava Sciences and Anavex Life Sciences, also in the biotech sector, have faced scrutiny over their financial reporting and internal controls, highlighting the importance of robust financial oversight.
  • The fact that the change was not due to disagreements is a positive sign, but the underlying issues need to be addressed.

Stakeholder Impact

  • Shareholders may be concerned about the going concern note and material weakness in internal controls.
  • Creditors may view the company as a higher risk due to the financial uncertainties.

Key Dates

DateDescription
2024-05-05Baker Tilly US, LLP was dismissed and Haskell & White LLP was appointed as the new independent registered public accounting firm.
2024-05-09Date of the 8-K filing and Baker Tilly's letter confirming agreement with the disclosures.

Keywords

auditor, accounting firm, Baker Tilly, Haskell & White, internal controls, financial reporting, going concern, audit committee

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.